Clinical Trial: Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

Share this article:
Clinical Trial: Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

Sponsor and Collaborators

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Contact
Contact: Melissa Bondy, PhD
713-794-5264

Principal Investigator

Melissa Bondy, PhD M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier

NCT00526578
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Pancreatic Cancer Clinical Trials

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Pancreatic Cancer Clinical Trials

Clinical Trial: BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology ...

Clinical trial focusing on BrUOG 278. BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Clinical Trial: Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical trial focusing on mirtazapine and gemcitabine. Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical Trial: Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX ...

Clinical trial focusing on sterotactic radion therapy and Folfirinox. Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer